Targeting renin using synthetic renin inhibitors induced apoptosis and reduced the growth of commercial glioma cells in vitro [26], while a similar observation was reported using an siRNA against ATP6AP2 [21]. Here, ATP6AP2 is linked to central nervous system cancer.